Kidney cancer drugs equal in prolonging survival

THURSDAY, Aug. 22 -- The drug pazopanib works as well as sunitinib for treating advanced kidney cancer, but it has milder side effects, a new study finds.

http://www.abc12.com/story/23228714/kidney-cancer-drugs-equal-in-prolonging-survival-study